Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-03-07 Sale |
2024-03-11 7:05 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
65,012 | $21.02 | $1,366,552 | 162,311 (Indirect Direct) |
View |
2024-03-04 Sale |
2024-03-06 5:37 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
18,324 | $21.34 | $391,056 | 227,323 (Indirect Direct) |
View |
2024-03-01 Sale |
2024-03-05 4:34 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
1,189 | $22.03 | $26,194 | 178,864 (Direct) |
View |
2024-03-01 Sale |
2024-03-05 4:31 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
18,844 | $21.77 | $410,234 | 127,109 (Direct) |
View |
2024-02-28 Sale |
2024-03-01 6:26 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
14,785 | $21.57 | $318,881 | 23,691 (Direct) |
View |
2024-02-27 Sale |
2024-02-29 4:26 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
10,156 | $21.03 | $213,581 | 145,953 (Direct) |
View |
2024-01-03 Sale |
2024-01-04 4:30 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
12,000 | $20 | $240,000 | 15,632 (Direct) |
View |
2024-01-02 Sale |
2024-01-04 4:30 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
16,670 | $19.17 | $319,564 | 21,019 (Direct) |
View |
2023-12-19 Sale |
2023-12-21 4:26 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
9,316 | $19.13 | $178,215 | 37,689 (Direct) |
View |
2023-12-07 Sale |
2023-12-11 4:20 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
28,600 | $17.65 | $504,758 | 156,109 (Direct) |
View |
2023-09-05 Sale |
2023-09-06 7:03 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
400 | $17.53 | $7,012 | 241,121 (Direct) |
View |
2023-07-25 Sale |
2023-07-27 4:30 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
29,000 | $19.14 | $555,160 | 182,127 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-05 Option Award |
2024-06-07 4:40 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
22,213 | $0 | 35,110 (Direct) |
View |
2024-06-06 Exercise |
2024-06-07 4:40 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
4,373 | $0 | 35,110 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:39 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director |
22,213 | $0 | 103,553 (Direct) |
View |
2024-06-06 Exercise |
2024-06-07 4:39 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director |
4,373 | $0 | 103,553 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:37 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director |
22,213 | $0 | 31,586 (Direct) |
View |
2024-06-06 Exercise |
2024-06-07 4:37 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director |
4,373 | $0 | 31,586 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:36 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director |
22,213 | $0 | 31,586 (Direct) |
View |
2024-06-06 Exercise |
2024-06-07 4:36 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director |
4,373 | $0 | 31,586 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:35 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
22,213 | $0 | 31,586 (Direct) |
View |
2024-06-06 Exercise |
2024-06-07 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
4,373 | $0 | 31,586 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:07 pm |
N/A 2034-06-04 |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
82,506 | $0 | 2,831,529 (Indirect) |
View |
2024-05-03 Option Award |
2024-05-07 4:46 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
747 | $0 | 9,271 (Direct) |
View |
2024-05-03 Exercise |
2024-05-07 4:46 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
747 | $0 | 9,271 (Direct) |
View |
2024-04-26 Exercise |
2024-04-30 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
991 | $0 | 20,243 (Direct) |
View |
2024-04-26 Tax Withholding |
2024-04-30 4:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
509 | $17.88 | 20,243 (Direct) |
View |
2024-04-04 Option Award |
2024-04-08 5:22 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
174,700 | $0 | 401,351 (Direct) |
View |
2024-04-08 Exercise |
2024-04-08 5:22 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
9,992 | $0 | 401,351 (Direct) |
View |
2024-04-08 Tax Withholding |
2024-04-08 5:22 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
4,075 | $17.9 | 401,351 (Direct) |
View |
2024-04-04 Option Award |
2024-04-08 5:21 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
48,950 | $0 | 111,000 (Direct) |
View |
2024-04-08 Exercise |
2024-04-08 5:21 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
2,497 | $0 | 111,000 (Direct) |
View |
2024-04-08 Tax Withholding |
2024-04-08 5:21 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
733 | $17.9 | 111,000 (Direct) |
View |
2024-04-04 Option Award |
2024-04-08 5:20 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
44,607 | $0 | 77,549 (Direct) |
View |
2024-04-08 Exercise |
2024-04-08 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
2,694 | $0 | 77,549 (Direct) |
View |
2024-04-08 Tax Withholding |
2024-04-08 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
791 | $17.9 | 77,549 (Direct) |
View |
2024-04-04 Option Award |
2024-04-08 5:19 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
48,631 | $0 | 79,058 (Direct) |
View |
2024-04-08 Exercise |
2024-04-08 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
2,477 | $0 | 79,058 (Direct) |
View |
2024-04-08 Tax Withholding |
2024-04-08 5:19 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,353 | $17.9 | 79,058 (Direct) |
View |
2024-04-04 Option Award |
2024-04-08 5:18 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
28,350 | $0 | 70,540 (Direct) |
View |
2024-04-08 Exercise |
2024-04-08 5:18 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
3,932 | $0 | 70,540 (Direct) |
View |
2024-04-08 Tax Withholding |
2024-04-08 5:18 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
1,666 | $17.9 | 70,540 (Direct) |
View |
2024-04-04 Option Award |
2024-04-08 5:17 pm |
N/A 2034-03-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
48,866 | $0 | 189,781 (Direct) |
View |
2024-04-08 Exercise |
2024-04-08 5:17 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
2,726 | $0 | 189,781 (Direct) |
View |
2024-04-08 Tax Withholding |
2024-04-08 5:17 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
801 | $17.9 | 189,781 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 5:25 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,750 | $0 | 22,118 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:25 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
514 | $19.7 | 22,118 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 5:23 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
1,773 | $0 | 129,417 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:23 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
521 | $19.7 | 129,417 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 5:22 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
6,482 | $0 | 186,333 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:22 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
1,903 | $19.7 | 186,333 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 5:21 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
2,558 | $0 | 26,734 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:21 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
1,084 | $19.7 | 26,734 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,612 | $0 | 19,985 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
880 | $19.7 | 19,985 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 5:18 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
1,624 | $0 | 50,911 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-03 5:18 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
477 | $19.7 | 50,911 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:34 pm |
N/A 2025-12-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
656 | $0 | 178,864 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:34 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
656 | $1.59 | 178,864 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:31 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
18,844 | $1.86 | 127,109 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:31 pm |
N/A 2026-09-13 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
18,844 | $0 | 127,109 (Direct) |
View |
2024-03-01 Exercise |
2024-03-01 6:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
4,014 | $13.88 | 23,691 (Direct) |
View |
2024-02-28 Exercise |
2024-03-01 6:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
10,771 | $8.83 | 23,691 (Direct) |
View |
2024-02-28 Exercise |
2024-03-01 6:26 pm |
N/A 2029-09-16 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
14,785 | $0 | 23,691 (Direct) |
View |
2024-01-15 Option Award |
2024-03-01 6:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
583 | $12.35 | 23,691 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
10,156 | $1.86 | 145,953 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:26 pm |
N/A 2026-09-13 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
10,156 | $0 | 145,953 (Direct) |
View |
2024-01-03 Exercise |
2024-01-04 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
12,000 | $8.83 | 15,632 (Direct) |
View |
2024-01-03 Exercise |
2024-01-04 4:30 pm |
N/A 2029-09-16 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
12,000 | $0 | 15,632 (Direct) |
View |
2024-01-02 Exercise |
2024-01-04 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
16,670 | $13.88 | 21,019 (Direct) |
View |
2024-01-02 Exercise |
2024-01-04 4:30 pm |
N/A 2028-08-05 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
16,670 | $0 | 21,019 (Direct) |
View |
2023-12-19 Exercise |
2023-12-21 4:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
9,316 | $13.88 | 37,689 (Direct) |
View |
2023-12-19 Exercise |
2023-12-21 4:26 pm |
N/A 2028-08-05 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
9,316 | $0 | 37,689 (Direct) |
View |
2023-12-07 Exercise |
2023-12-11 4:20 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
28,600 | $1.86 | 156,109 (Direct) |
View |
2023-12-07 Exercise |
2023-12-11 4:20 pm |
N/A 2026-09-13 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
28,600 | $0 | 156,109 (Direct) |
View |
2023-11-03 Option Award |
2023-11-07 4:33 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
2,777 | $0 | 10,554 (Direct) |
View |
2023-11-03 Exercise |
2023-11-07 4:33 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
2,777 | $0 | 10,554 (Direct) |
View |
2023-10-04 Exercise |
2023-10-06 4:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
175 | $0 | 17,355 (Direct) |
View |
2023-10-04 Tax Withholding |
2023-10-06 4:26 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
52 | $16.01 | 17,355 (Direct) |
View |
2023-09-01 Tax Withholding |
2023-09-06 7:08 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
1,383 | $17.76 | 60,917 (Direct) |
View |
2023-09-01 Option Award |
2023-09-06 7:08 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
30,689 | $0 | 60,917 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 7:08 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
4,707 | $0 | 60,917 (Direct) |
View |
2023-07-15 Option Award |
2023-09-06 7:08 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER |
581 | $12.35 | 60,917 (Direct) |
View |
2023-09-01 Tax Withholding |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
1,896 | $17.76 | 68,952 (Direct) |
View |
2023-09-01 Option Award |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
45,113 | $0 | 68,952 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
3,471 | $0 | 68,952 (Direct) |
View |
2023-07-15 Option Award |
2023-09-06 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER |
292 | $12.35 | 68,952 (Direct) |
View |
2023-09-01 Tax Withholding |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
6,619 | $17.76 | 470,185 (Direct) |
View |
2023-09-01 Option Award |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
181,425 | $0 | 470,185 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO |
16,561 | $0 | 470,185 (Direct) |
View |
2023-09-01 Tax Withholding |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
1,338 | $17.76 | 76,486 (Direct) |
View |
2023-09-01 Option Award |
2023-09-06 7:06 pm |
N/A 2033-08-31 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
49,050 | $0 | 76,486 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 7:06 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER |
4,556 | $0 | 76,486 (Direct) |
View |
2023-09-01 Tax Withholding |
2023-09-06 7:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
1,378 | $17.76 | 185,121 (Direct) |
View |
2023-09-01 Option Award |
2023-09-06 7:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
49,635 | $0 | 185,121 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 7:04 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER |
4,691 | $0 | 185,121 (Direct) |
View |
2023-09-05 Exercise |
2023-09-06 7:03 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
400 | $1.86 | 241,121 (Direct) |
View |
2023-09-01 Tax Withholding |
2023-09-06 7:03 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
1,241 | $17.76 | 241,121 (Direct) |
View |
2023-09-01 Option Award |
2023-09-06 7:03 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
45,470 | $0 | 241,121 (Direct) |
View |
2023-09-01 Exercise |
2023-09-06 7:03 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
4,623 | $0 | 241,121 (Direct) |
View |
2023-07-25 Exercise |
2023-07-27 4:30 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
29,000 | $1.86 | 182,127 (Direct) |
View |
2023-07-25 Exercise |
2023-07-27 4:30 pm |
N/A 2026-09-13 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER |
29,000 | $0 | 182,127 (Direct) |
View |
2023-06-29 Exercise |
2023-07-03 4:15 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director |
5,000 | $0 | 76,967 (Direct) |
View |